NCT03481530View on ClinicalTrials.gov

Role of CGMS Usage in Predicting Risk for Hypoglycemia

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

January 13, 2020

Study Completion Date

September 30, 2025

Conditions
Type 2 Diabetes MellitusHypoglycemia
Interventions
DEVICE

Continuing Glucose Monitor System

glucose monitoring

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03481530 - Role of CGMS Usage in Predicting Risk for Hypoglycemia | Biotech Hunter | Biotech Hunter